Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Dulaglutide & Type 2 diabetes (T2D), dulaglutide is approved by the FDA as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years and older with type 2 diabetes. It is also approved as monotherapy or in combination with other antidiabetes agents and has cardiovascular‑risk‑reduction indications in adults with T2D and established cardiovascular disease or multiple risk factors.
[125469s051lbl](https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125469s05…